Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Apr 27, 2004

29777_dirs_2004-04-27_f7337b28-92ea-403e-aecf-dfd0bb63099f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-23

Reporting Person: ROBERTS ROY S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-04-23 Common shares without par value A 1577 $41.20 Acquired 11492 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-04-23 Option (right to buy) $41.20 A 5825 Acquired 2014-04-22 common shares (5825) Direct

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F2: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b). It contains a replacement option feature.